期刊文献+

冠心病患者循环内皮祖细胞与尿酸检测及相关性 被引量:24

The Relationship between Uric Acid and Circulating Endothelial Progenitor Cell in Patients with Coronary Artery Disease and Its Clinical Significance
下载PDF
导出
摘要 目的探讨冠心病患者循环内皮祖细胞与尿酸的关系及临床意义。方法42例冠心病患者均经选择性冠状动脉造影证实有明显的冠状动脉狭窄;36例对照组经临床检查和选择性冠状动脉造影排除冠心病。测定各组患者血清尿酸水平;采集研究对象外周血进行内皮祖细胞的分离培养,14天后倒置相差显微镜下计数细胞克隆形成单位评估循环内皮祖细胞水平。结果冠心病组血清尿酸水平明显高于对照组(P<0.01),单支与多支冠状动脉病变组尿酸水平差异无显著性(P>0.05)。冠心病组中稳定型心绞痛组及急性冠状动脉综合征组循环内皮祖细胞水平均明显低于对照组(P<0.01);单支、双支、三支冠状动脉病变组内皮祖细胞水平均显著低于对照组(P<0.01)。血清尿酸与循环内皮祖细胞水平呈负相关(r=-0.382,P=0.037)。结论冠心病患者血清尿酸水平与循环内皮祖细胞水平呈负相关,血清尿酸可能通过抑制内皮祖细胞数量从而减弱内皮祖细胞参与损伤内皮修复的能力,与冠心病发生及临床表现相关。 Aim To investigate the correlation between uric acid and circulating endothelial progenitor cell ( EPC ) in patients with coronary artery disease (CAD)and its clinical significance. Methods 78 cases were divided into 3 groups: stable angina pectoris (SAP)group( n = 18), acute coronary syndrome (ACS)group( n= 24)and control group ( n = 36), and CAD patients were divided into 3 groups according to the result of coronary angiography: single vessel disease group( n = 18), double vessels disease group ( n =14)and triple vessels disease group( n= 10). The concentration of serum uric acid was measured with method of uric acid enzyme. Total mononuclear cell were isolated from peripheral blood by Ficoll density gradient centrihtgation, and were cultured in M199 medium supplemented with 20% fetal bovine serum , 50μg/L vascular endothelial growth factor (VEGF). After 14 days cultured, the number of colony-forming units of EPC were counted by phase-contrast microscope. Results The uric acid level in the CAD group was significantly higher than those in control group ( P〈0.01 ), and there was no statistical difference between the uric acid level of single vessel disease group and that of multiple vessels disease groups (P〉0.05). The number of colony-forming units of circulating EPC in CAD group (including SAP and ACS groups)was significantly lower than those in control group ( P〈0.01 ), and the circulating EPC level of single, double, triple vessels disease group were significantly lower than that of control group ( P〈0.01 ). It was also observed there was a strong negative correlation between the concentration of serum uric acid and the number of colony-forming units of circulating EPC ( r = - 0. 382, P = 0. 037 ). Conclusions The serum uric acid concentration in CAD group was higher than that of control group, but the levels of uric acid were independent of the degree of coronary artery disease. The levels of circulating EPC of CAD patients were lower than those of healthy person. Uric acid and EPC were associated with CAD and the severity of coronary artery lesion, and the level of uric acid was negatively correlated with the number of colony-forming units of circulating EPC. These data indicate that uric acid may impair EPC-mediated reendothelialization after endothelial cell injury by inhibiting the number of the EPC, and uric acid and EPC are correlated with the degree of patient's condition and the clinical situation of cardiovascular disease.
出处 《中国动脉硬化杂志》 CAS CSCD 2006年第1期57-60,共4页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金资助项目(30470729)
关键词 内科学 冠心病患者循环内皮祖细胞与尿酸的关系 免疫细胞化学 内皮祖细胞 尿酸 细胞培养 冠心病 Endothelial Progenitor Cell Uric Acid Cell Culture Coronary Artery Disease Endothelial Cell Mononuclear Cell
  • 相关文献

参考文献11

  • 1Culleton BF,Larson MG,KannelWB,Levy D.Serum uric acid and risk for cardiovascular disease and death:The Farmingham Heart disease[J].Ann Intern Med,1999,131 (1):7-13
  • 2Fang J,Alderman MH.Serum uric acid and cardiovascular mortality:The NHANES I epidemiologic follow-up study[J].J Am Med Associat,2000,283 (18):2 404-410
  • 3Szmitko PE,Fedak PW,Weisel RD,Stewart DJ,Kutryk MJ,Verma S,et al.Endothelial progenitor cell:new hope for a broken heart[J].Circulation,2003,107 (24):3 093-100
  • 4Vasa M,Fichtlscherer S,Aicher A,Adler K,Uribich C,Martin H,et al.Number and migratory activity of circulating endothelial progenitor cell inversely correlate with risk factors for coronary artery disease[J].Circ Res,2001,89 (1):e1-7
  • 5Kalka C,Masuda H,Takahashi T,Kalka-Moll WM,Silver M,Kearney M,et al.Transplantation of ex vivo expanded endothelial progenitor cell for therapeutic neovascularization[J].Proc Natl Acad Sci USA,2000,97 (7):3 422-427
  • 6Brand FN,Mcgee DL,Kannel WB,Stokes J,Castelli WP.Hyperuricemia as a risk of coronary heart disease:the Framingham study[J].Am J Epidemiol,1985,121 (1):11-18
  • 7Walter DH,Kilian Ritting,Ferdinand HB,Kirchmair R,Silver M,Murayama T,et al.Statin therapy accelerates reendothelialization:a novel effect involving mobilization and incorporation of bone marrow derived endothelial progenitor cell[J].Circulation,2002,105 (25):3 024-027
  • 8Werner N,Kosiol S,Schiegl T,Ahlers P,Walenta K,Link A,et al.Circulating endothelial progenitor cell and cardiovascular outcomes[J].N Engl J Med,2005,353 (10):999-1 007
  • 9Wannamethee SG,Shaper AG,Whincup PH.Serum uric acid and the risk of major coronary heart disease events[J].Heart,1997,78 (2):147-153
  • 10Mihail H,Wolfgang Erl,Peter CW.Endothelial progenitor cell mobilization,differentiation,and homing[J].Arterioscler Thromb Vasc Biol,2003,23 (7):1 185-189

二级参考文献23

  • 1周音频,黄岚.血管内皮祖细胞动员在损伤血管修复中的作用及调控因素[J].中国动脉硬化杂志,2004,12(2):233-234. 被引量:12
  • 2Suda T, Takakura N, Oike Y. Hematopoiesis and angiogenesis. Int J Hematol, 2000, 71 (2): 99-107.
  • 3Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for cornary artery disease. Circ Res, 2001, 89 (1): e1-e7.
  • 4Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Clin Invest, 2000, 105 (11): 1 527-536.
  • 5Hirschi KK, Goodell MA. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther, 2002, 9 (10): 648-652.
  • 6Takahashi T , Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med, 1999, 5: 434-438.
  • 7Mireille AM, Mark B, Todd G, Omar F, Linda M, Steve K, et al. GM-CSF and SDF treatment induces neovasculogenesis in a mouse ischemic hindlimb model. J American College Surgeons, 2004, 199(3): 105.
  • 8Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J, 1999, 18 (14): 964-972.
  • 9Kalka C, Macuda H, Takahashi T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97: 3 422-427.
  • 10Herssig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al. Recruitment of stem and progenitor cells form the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 2002, 109: 625-637.

共引文献2

同被引文献224

引证文献24

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部